Cannabis firm CannTrust said Friday that federal licenses for one of its facilities have been reinstated, about nine months after the embattled producer was hit with suspensions over legal and regulatory breaches.
In September, Health Canada suspended the licenses held by CannTrust for its Niagara and Vaughan sites over noncompliance with the Cannabis Act and regulations.
Now Health Canada says the standard cultivation and processing licenses for the Niagara facility have been reinstated.
“Health Canada has reviewed all information submitted by CannTrust Inc. related to its Pelham site since its licences were suspended, and is satisfied with the actions the company has taken in response to the suspension,” the federal health department told Marijuana Business Daily via email.
In reinstating the CannTrust Niagara licenses, Health Canada cited:
- Significant personnel changes.
- Implementation of controls, processes and systems to mitigate the risks related to the original suspension.
- Improved recordkeeping.
- Comprehensive training for all staff.
With the newly reinstated licenses in hand, CannTrust says it will immediately recommence operations at the Niagara facility.
However, the company cannot provide a timeframe for when its products will be available, “which is dependent upon receiving a response from Health Canada to CannTrust’s licence reinstatement submission with respect to its Vaughan manufacturing facility,” it said in a press release.
In 2019, CannTrust received a “noncompliant” rating by Health Canada for operating unlicensed grow rooms.
The company was granted creditor protection in March under the Companies’ Creditors Arrangement Act by the Ontario Superior Court of Justice.
The court also issued an order authorizing and directing CannTrust to undertake a sale and investment solicitation process.
Written by Matt Lamers.
View the original article at here.
Marijuana Business Daily